Skip to main content

New HRT Guidelines Issued by USPSTF


May 28, 2012 — Menopausal hormone therapy (HRT) reduced risk of fractures but increased risk for stroke, thromboembolic events, gallbladder disease, and urinary incontinence, according to a systematic review of articles published after 2002. Whereas estrogen alone decreased the risk for breast cancer, estrogen plus progestin increased risk for probable dementia and breast cancer. This new review, published online May 29 in the Annals of Internal Medicine, will be used to update the US Preventive Services Task Force recommendations.
"Menopausal hormone therapy to prevent chronic conditions is currently not recommended because of its adverse effects," write Heidi D. Nelson, MD, MPH, from the Oregon Health & Science University in Portland, and colleagues.
"The current indications for use from the U.S. Food and Drug Administration include short-term treatment of menopausal symptoms, such as vasomotor hot flashes or urogenital atrophy, and prevention of osteoporosis."
For the systematic review, Dr. Nelson and colleagues searched MEDLINE for articles published from January 2002 to November 2011, the Cochrane Central Register of Controlled Trials and Cochrane Database of Systematic Reviews through the third quarter of 2011, Scopus, and bibliographies of retrieved articles. They limited inclusion to studies that were randomized, placebo-controlled trials of menopausal hormone therapy; evaluation of primary prevention of chronic conditions; and English-language publication since 2002.
Data were extracted regarding participants, study design, analysis, follow-up, and findings. Using established criteria, 2 investigators independently rated study quality.
The investigators identified 9 fair-quality trials meeting the inclusion criteria. Most of the findings came from the Women's Health Initiative (WHI), with 11 years of follow-up and collection of data most relevant to postmenopausal American women.
In the WHI, estrogen plus progestin therapy was associated with 46 fewer fractures per 10,000 woman-years. However, women taking HRT had an increased risk for invasive breast cancer (8 more per 10,000 woman-years), stroke (9 more per 10,000 woman-years), deep venous thrombosis (12 more per 10,000 woman-years), pulmonary embolism (9 more per 10,000 woman-years), lung cancer death (5 more per 10,000 woman-years), gallbladder disease (20 more per 10,000 woman-years), dementia (22 more per 10,000 woman-years), and urinary incontinence (872 more per 10,000 woman-years).
The risk for breast cancer was greater in women who previously used oral contraceptives or menopausal estrogen plus progestin therapy, or who were current smokers.
Estrogen-only therapy reduced the risk for several adverse outcomes, including fracture (56 fewer per 10,000 woman-years), invasive breast cancer (8 fewer per 10,000 woman-years), and mortality (2 fewer per 10,000 woman-years). However, the treatment increased risks for stroke (11 more per 10,000 woman-years), deep venous thrombosis (7 more per 10,000 woman-years), gallbladder disease (33 more per 10,000 woman-years), and urinary incontinence (1271 more per 10,000 woman-years).
The investigators could not identify subgroups based on age or comorbid conditions in which outcomes of menopausal HRT were consistently different.
Limitations of this review included those inherent in the trials themselves, such as low adherence, high dropout rate, insufficient power to detect risks for some outcomes, and assessment of few regimens.
"Continuing research is needed on such long-term outcomes as cancer and death to fully understand the implications of hormone therapy," the reviewers conclude.
The Agency for Healthcare Research and Quality funded this study and has financial relationships with some of its authors. Disclosures can be viewed at on the journal's Web site .

Comments

Post a Comment

Popular posts from this blog

Contact Precautions May Have Unintended Consequences

Contact precautions, including gloves, gowns, and isolated rooms, have helped stem the transmission of hospital pathogens but have also had some negative consequences, according to findings from a new study. Healthcare worker (HCWs) visited patients on contact precautions less frequently than other patients and spent less time with those patients when they did visit, report Daniel J. Morgan, MD, from the University of Maryland School of Medicine and the Veterans Affairs (VA) Maryland Health Care System, Baltimore, and colleagues. Moreover, patients on contact precautions also received fewer outside visitors. "Less contact with HCWs suggests that other unintended consequences of contact precautions still exist," Dr. Morgan and coauthors write. "The resulting decrease in HCW contact may lead to increased adverse events and a lower quality of patient care due to less consistent patient monitoring and poorer adherence to standard adverse event prevention methods (such...
Post a Comment
Read more

Obama Renominates Tavenner to Be CMS Chief

President Barack Obama yesterday renominated Marilyn Tavenner, the acting administrator of the Centers for Medicare & Medicaid Services (CMS), to serve in that post without the caveat of "acting" attached to it. If the Senate approves her nomination, Tavenner will be the first confirmed, full-fledged CMS administrator since Mark McClellan, MD, PhD, stepped down from that position in October 2006, during the George W. Bush administration. Dr. McClellan's successors either were acting administrators or, in the case of Donald Berwick, MD, who was Tavenner's immediate predecessor, a recess appointment. As illustrated by Dr. Berwick's  CMS history , Senate confirmation can be tough to get when one party has enough votes to filibuster and otherwise stymie a nomination by an opposing party's president. That was the case when Obama nominated Dr. Berwick, whom Senate Republicans portrayed as an advocate of healthcare rationing, a characterization denied by t...
Post a Comment
Read more

Secondary Prevention: Clinical Approaches to Managing the Higher-Risk Patient with Heart Disease

INCIDENCE/PREVALENCE/BURDENS ASSOCIATED WITH CARDIOVASCULAR DISEASE (CVD) The prevention of an initial and recurrent cardiovascular event and other complications, such as diabetes and kidney failure [also known as end-stage renal disease (ESRD) or chronic kidney disease (CKD) stage 5] is an important goal in patients with a history of CVD. Each year, approximately 185,000 Americans suffer a recurrent stroke, approximately 470,000 will have a recurrent coronary attack, and an estimated 325,000 will suffer a recurrent myocardial infarction. [1]  Secondary prevention strategies offer the opportunity to prevent further complications and improve outcomes by early detection and management of common comorbidities. The burden on public health and the costs associated with chronic illnesses such as CVD, CKD, and diabetes remain high. An estimated 82.6 million American adults (1 in 3) have 1 or more types of CVD. [1]  Heart failure is the fastest-growing clinical cardiac disease ...
Post a Comment
Read more